Kurtz Theodore W, Dominiczak Anna F, DiCarlo Stephen E, Pravenec Michal, Morris R Curtis
From the Department of Laboratory Medicine, University of California, San Francisco (T.W.K.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (A.F.D.); Department of Physiology, Wayne State University, Detroit, MI (S.E.D.); Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic (M.P.); and Department of Medicine, University of California, San Francisco (R.C.M.).
Hypertension. 2015 May;65(5):932-41. doi: 10.1161/HYPERTENSIONAHA.114.05092. Epub 2015 Mar 9.
This critical review directly challenges the prevailing theory that a transient increase in cardiac output caused by genetically mediated increases in activity of the ENaC in the aldosterone sensitive distal nephron, or of the NCC in the distal convoluted tubule, accounts entirely for the hemodynamic initiation of all Mendelian forms of salt-dependent hypertension (Figure 1). The prevailing theory of how genetic mutations enable salt to hemodynamically initiate Mendelian forms of salt-dependent hypertension in humans (Figure 1) depends on the results of salt-loading studies of cardiac output and systemic vascular resistance in nongenetic models of hypertension that lack appropriate normal controls. The theory is inconsistent with the results of studies that include measurements of the initial hemodynamic changes induced by salt loading in normal, salt-resistant controls. The present analysis, which takes into account the results of salt-loading studies that include the requisite normal controls, indicates that mutation-induced increases in the renal tubular activity of ENaC or NCC that lead to transient increases in cardiac output will generally not be sufficient to enable increases in salt intake to initiate the increased BP that characterizes Mendelian forms of salt-dependent hypertension (Table). The present analysis also raises questions about whether mutation-dependent increases in renal tubular activity of ENaC or NCC are even necessary to account for increased risk for salt-dependent hypertension in most patients with such mutations. We propose that for the genetic alterations underlying Mendelian forms of salt-dependent hypertension to enable increases in salt intake to initiate the increased BP, they must often cause vasodysfunction, ie, an inability to normally vasodilate and decrease systemic vascular resistance in response to increases in salt intake within dietary ranges typically observed in most modern societies. A subnormal ability to vasodilate in response to salt loading could be caused by mutation-related disturbances originating in the vasculature itself or in sites outside the vasculature (eg, brain or adrenal glands) that have the capacity to affect vascular function.
这篇批判性综述直接挑战了一种主流理论,该理论认为醛固酮敏感远端肾单位中由基因介导的上皮钠通道(ENaC)活性增加,或远曲小管中氯化钠协同转运蛋白(NCC)活性增加所引起的心输出量短暂增加,完全解释了所有孟德尔形式的盐依赖性高血压的血流动力学起始机制(图1)。关于基因突变如何使盐在血流动力学上引发人类孟德尔形式的盐依赖性高血压的主流理论(图1),依赖于在缺乏适当正常对照的非基因高血压模型中进行的盐负荷研究中心输出量和全身血管阻力的结果。该理论与包括对正常、盐抵抗对照中盐负荷引起的初始血流动力学变化进行测量的研究结果不一致。本分析考虑了包括必要正常对照的盐负荷研究结果,表明由ENaC或NCC的肾小管活性突变引起的心输出量短暂增加,通常不足以使盐摄入量增加引发孟德尔形式的盐依赖性高血压所特有的血压升高(表)。本分析还对ENaC或NCC的肾小管活性的突变依赖性增加对于解释大多数具有此类突变的患者盐依赖性高血压风险增加是否必要提出了疑问。我们提出,对于孟德尔形式的盐依赖性高血压的潜在基因改变,要使盐摄入量增加引发血压升高,它们通常必须导致血管功能障碍,即无法在大多数现代社会通常观察到的饮食范围内对盐摄入量增加做出正常的血管舒张和降低全身血管阻力的反应。对盐负荷的血管舒张能力不足可能是由血管系统本身或血管系统外(如大脑或肾上腺)的与突变相关的干扰引起的,这些部位有能力影响血管功能。